Company Profiles

driven by the PitchBook Platform

Abide Therapeutics

Description

Developer of an innovative therapeutic platform designed to target serine hydrolases. The company's therapeutic platform exploits the power of chemoproteomics to mine the serine hydrolase superfamily for novel drug targets, enabling health care providers to harness the therapeutic potential of serine hydrolases to yield drugs for treatment of a broad range of diseases in areas of unmet medical need.

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$6.6M

Latest Deal Amount

$8.8M

Total Amount Raised

2

Investors

Description

Developer of an innovative therapeutic platform designed to target serine hydrolases. The company's therapeutic platform exploits the power of chemoproteomics to mine the serine hydrolase superfamily for novel drug targets, enabling health care providers to harness the therapeutic potential of serine hydrolases to yield drugs for treatment of a broad range of diseases in areas of unmet medical need.

Website:

www.abidetx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

10835 Road to the Cure Suite 250 San Diego, CA 92121United States +1 (858) 427-2590
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Abide Therapeutics's full profile, request a free trial.

    Abide Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Abide Therapeutics Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Cardinal PartnersVenture CapitalMinority000 0000000 0000
    Cure Alzheimer's FundAngel (individual)000 0000000 0000
    Cardinal Partners Venture Capital
    Cure Alzheimer's Fund Angel (individual)

    Abide Therapeutics Executive Team (11)

    NameTitleBoard
    Seat
    Contact
    Info
    Cheri Grice Ph.DVice President, Chemistry
    Iain Fraser Ph.DVice President, Early Clinical Development
    Chan BealsChief Medical Officer
    Stan BlackburnChief Financial Officer
    Alan Ezekowitz Ph.DCo-Founder, Board Member, President & Chief Executive Officer
    Cheri Grice Ph.D Vice President, Chemistry
    Iain Fraser Ph.D Vice President, Early Clinical Development
    Chan Beals Chief Medical Officer
    Stan Blackburn Chief Financial Officer
    Alan Ezekowitz Ph.D Co-Founder, Board Member, President & Chief Executive Officer

    Abide Therapeutics Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Alan Ezekowitz Ph.DAbide TherapeuticsCo-Founder, Board Member, President & Chief Executive Officer000 0000
    Benjamin Cravatt Ph.DAbide TherapeuticsCo-Founder, Scientific Advisory Board & Board Member000 0000
    John ClarkeCardinal PartnersCo-Founder & Managing General Partner000 0000
    Nancy ThornberrySelfBoard Member000 0000
    Paul Schimmel Ph.DSelfCo-Founder & Board Member000 0000
    Alan Ezekowitz Ph.D Co-Founder, Board Member, President & Chief Executive Officer Abide Therapeutics
    Benjamin Cravatt Ph.D Co-Founder, Scientific Advisory Board & Board Member Abide Therapeutics
    John Clarke Co-Founder & Managing General Partner Cardinal Partners
    Nancy Thornberry Board Member Self
    Paul Schimmel Ph.D Co-Founder & Board Member Self
    Request full access to PitchBook